On 9 month 2 day, the China Association of Chinese Medicine held its founding meeting and first academic conference for the Committee on Development and Production of Classic Chinese Medicine Formulas at the Guangxi Building in Beijing. Attendees included Academician Zhang Boling from the China Academy of Chinese Medical Sciences; Deputy Director Zhou Jie of the Science and Technology Division of the National Administration of Traditional Chinese Medicine; Deputy Director Hou Weiwei of the Office of the National Administration of Traditional Chinese Medicine; Vice President Liu Zhanglin of the China Association of Chinese Medicine; Chief Chen Ronghu of the Science and Technology Division of the National Administration of Traditional Chinese Medicine; Party Secretary Zhu Xiaoxin of the Institute of Medicinal Materials, China Academy of Chinese Medical Sciences; Professor Liu Juyan, Vice General Manager and Chief Engineer of Guangzhou Pharmaceutical Group Co., Ltd., and Director of the National Engineering Research Center; Mr. Zhang Chunbo, Vice General Manager of Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd., and Chairman and General Manager of Zhongyi Pharmacy/Qixing Pharmacy; Professor Wang Zhimin, Chief Researcher at the China Academy of Chinese Medical Sciences and Director of the National Engineering Laboratory; Professor Qian Zhongzhi, Chief Expert of the Pharmacopoeia Commission of China; Professor Guo De'an, Researcher at the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and Director of the National Engineering Laboratory for Standardization of Chinese Medicine; and over 100 other experts from traditional Chinese medicine universities, research institutions across the country, and senior leaders of major enterprises in the Chinese medicine industry.
China Association of Chinese Medicine - Committee for R&D and Production of Classic Chinese Medicine Formulas
Team group photo
Liu Zhanglin, Vice President of the China Association of Traditional Chinese Medicine, chaired the meeting and outlined the background for its establishment.
The congress held the first election for the Special Committee. Zhang Chunbo and Wang Zhimin were elected as the inaugural Co-Chairpersons, while Ma Shuangcheng and others...34A specialist was elected as the Deputy Director of the Committee. The Committee appointed Fang Shuting and Liu Juyan as Honorary Directors. It also appointed Academic Advisors, including academicians Chen Keji, Zhang Boli, and Liu Changxiao; National Medical Master Jin Shiyuan; Professor Qian Zhongzhi; Researcher Guo De'an; and Professor Su Qingmin. [Representatives from] Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd., Taiji Group Co., Ltd., Guangzhou Baiyunan H&H Traditional Chinese Medicine Co., Ltd., among others...18 companies serve as deputy director units: Guangzhou Baiyunshan Chenliji Pharmaceutical Co., Ltd., Guangzhou Baiyunshan Xingqun Pharmaceutical Co., Ltd., Shandong Wo...Huayao Pharmaceutical Technology Co., Ltd.Wait16 enterprises serve as executive member units.
Academic Advisor Academician Zhang Boling of the Special Committee Professor Qian Zhongzhi, Academic Advisor of the Special Committee
Guo De'an, Research Fellow and Academic Advisor of the Special Committee
Prof. Liu Juyan, Honorary Director of the Special Committee
Deputy Director Zhou Jie of the Science and Technology Department of the National Administration of Traditional Chinese Medicine (NATCM) attended the conference and delivered a keynote address. Representing the NATCM, he congratulated the establishment of the Special Committee on R&D and Production of Classic Chinese Medicine Formulas. Deputy Director Zhou emphasized that inheriting, promoting, and effectively utilizing traditional Chinese medicine remains a long-term mission. He urged the committee to fully mobilize industry resources to build a professional national platform for research, development, and sharing of classic Chinese medicine formulas. With integrity and determination, the committee should work together to advance and promote the cause of traditional Chinese medicine.
Deputy Director Zhou Jie of the Science and Technology Department, National Administration of Traditional Chinese Medicine, attended the conference and delivered a speech.
Chairman Zhang Chunbo and Chief Researcher Wang Zhimin, representing the first Special Committee, expressed gratitude to the China Association of Traditional Chinese Medicine (CATCM) and all leaders and experts for their strong support of the Special Committee on R&D and Production of Classic Prescriptions from Traditional Chinese Medicine. They also outlined the committee's purpose and mission. The Special Committee will be market-driven, focusing on the research, development, and production of classic prescriptions from ancient TCM texts, with authentic medicinal materials and high-quality processed slices as key supports, to guide the work of classic prescriptions in TCM.Establishing "material standards" for the standardized development, production, and quality specification formulation and promotion of Chinese medicine preparations. Building a national professional service platform dedicated to the development, innovation, sustainability, openness, and sharing of classic Chinese medicine formulas. This initiative aims to advance high-quality R&D, standardized production, standardization, and industrialization of these formulas, enhancing their modernization and global influence.
Chairman Zhang Chunbo, Director of the Special Committee, delivered a speech.
Director Wang Zhimin, Chief Researcher of the Special Committee, delivered a speech.
Academician Zhang Boli of the Chinese Academy of Engineering attended the conference and delivered a keynote speech, highlighting China's remarkable achievements in traditional Chinese medicine (TCM) and recent advancements in herbal medicines. He addressed the challenges facing TCM development and outlined its future prospects. Academician Zhang emphasized that ensuring the quality of herbal medicines while accurately defining their clinical roles is paramount for developing new drugs, offering valuable insights for the research and development of classic prescriptions. Integrating TCM's original thinking with modern technology will yield innovative breakthroughs, open up new research frontiers, and lead global life sciences forward.
Academician Zhang Boli of the Chinese Academy of Engineering attended and delivered a keynote speech.
Additionally, Chen Ronghu, Division Chief of the National Administration of Traditional Chinese Medicine, and Hou Weiwei, Deputy Director of the Office of the National Administration of Traditional Chinese Medicine, respectively addressedDelivered keynote speeches on "Innovation-Driven Development of the Chinese Medicine Industry" and "Key Provisions of the Traditional Chinese Medicine Law and Issues Requiring In-Depth Study," addressing national policies and regulations governing TCM development today, with a particular focus on the impact of the enactment and implementation of the TCM Law.
During the preparation phase of the Special Committee, the total number of confirmed initial members was136 people， InitialMember Organizations34，Aggregates the leading enterprises and institutions currently engaged in research on classic patent formulas., forming a team of scientists led by academicians.